RDIF, Morepen Laboratories Announce Production Of Test Batch Of Sputnik V in India
The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund), and Morepen…
Honeywell’s Authentication Technology To Prevent Counterfeit Pharmaceutical Products In India
Honeywell announced digital authentication technology for pharmaceutical products in a bid to…
Calibre Scientific Acquires LINARIS Biologische Produkte To Expand Product Portfolio
Calibre Scientific has announced the acquisition of LINARIS Biologische Produkte, a life…
mHealth Companies Raise Nearly $2 Billion In First Nine Months of 2020
Bengaluru, NFAPost: mHealth category is witnessing a significant surge in funding amid…
India staring at opportunity to ramp up R&D facilities: JLL report
Amritsar, NFA Post: India is looking at a great opportunity to ramp…
Urgently Notify e-Pharmacy Rules: IAMAI
Regulatory uncertainty discouraging new investment Leading industry representatives have urged the government…
Bayer’s Aflibercept Injection (EyleaTM) For Intravitreal Use Receives DCGI Approval
· Intravitreal Aflibercept is a highly targeted, evidence-based treatment administered via injection directly…
BDR Pharmaceutical To Launch 400mg Advanced Version Of BDFAVI To Treat Covid-19
Bengaluru, NFAPost: BDR Pharma had earlier received approval from Drugs Controller General…
Nitin Gadkari Launches Johari Digital Healthcare Ltd Steriliser
MUMBAI, NFAPost: MSME, Road Transport & Highways Nitin Gadkari launched a new product ‘ATULYA’,…
AstraZeneca’s Dapagliflozin Approves In India For Treatment Of Patients With Heart Failure
Dapagliflozin (Forxiga) is the first SGLT-2 inhibitor proven to significantly reduce the…
